ArticleFrontiers in immunology2021

A New Method for Optimizing Sepsis Therapy by Nivolumab and Meropenem Combination: Importance of Early Intervention and CTL Reinvigoration Rate as a Response Marker.

Avi Gillis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.